Latest Breaking News On - University of houston college pharmacy - Page 9 : comparemela.com

FDA Accepts Interim Analysis Plan for Ongoing Phase 2b Ibezapolstat Clinical Trial and Acurx Announces Presentations at ECCMID 2023 Scientific Conference

FDA has accepted an Interim Analysis Plan for an IDMC to assess clinical outcome when 36 patients are enrolled in the Company s Ph2b clinical trial of.

Acurx Pharmaceuticals (ACXP) Announces FDA Accepts Interim Analysis Plan for Ongoing Phase 2b Ibezapolstat Clinical Trial

Oral antiviral CD04872SC shows promise in neutralizing COVID-19 variants, offering hope for broad-spectrum treatment

Researchers discover a small molecule drug candidate that could provide immediate protection against infection with SARS-CoV-2.

Molecule neutralising SARS-CoV-2 virus found could reduce infection duration upon exposure

(This story has not been edited by THE WEEK and is auto-generated from a PTI

This Drug Helps Treat Opioid Addiction. Why Is it So Hard to Get?

By Anissa Durham | Word In Black - Buprenorphine helps diminish withdrawal symptoms and cravings of individuals with opioid use disorder. But its controversial background makes it difficult to access.